22nd Century Group

$1.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-1.38%) Today
-$0.01 (-0.70%) As of 12:59 AM UTC after-hours

Why Robinhood?

You can buy or sell XXII and other stocks, options, and ETFs commission-free!

About XXII

22nd Century Group Inc., also called 22nd Century Group, is a plant biotechnology company, which engages in the development of technology that will allow increasing or decreasing the level of nicotine and nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. Its products include X-22, modified risk cigarettes, spectrum government research cigarettes, magic 0 and magic 2, moonlight, red sun, variable nicotine-level research cigarettes, and verfola. The company was founded on September 12, 2005 and is headquartered in Clarence, NY. The listed name for XXII is 22nd Century Group Inc.

CEO
James A Mish
Employees
67
Headquarters
Clarence, New York
Founded
2005
Market Cap
198.57M
Price-Earnings Ratio
Dividend Yield
Average Volume
4.75M
High Today
$1.53
Low Today
$1.38
Open Price
$1.50
Volume
1.64M
52 Week High
$1.80
52 Week Low
$0.55

Collections

XXII Earnings

-$0.08
-$0.05
-$0.03
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 10, Pre-Market

You May Also Like